MultiCare Regional Cancer Center - Gig Harbor

Gig Harbor, Washington 98335

0 studies enrolling now · 5 studies all time

What they study most

Depression, HER2-Positive Primary Breast Cancer, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Metastatic Castration Resistant Prostate Cancer, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer, Prostate Cancer, Residual Invasive Breast Cancer

Studies at this site

• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer — Running, not enrolling
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE — Stopped early
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed